Multimodal classification of Alzheimer's disease and mild cognitive impairment

NeuroImage

Volumn 55, Issue 3, 2011, Pages 856-867

  Zhang, Daoqiang ^a   Wang, Yaping ^a,b   Zhou, Luping ^a   Yuan, Hong ^a   Shen, Dinggang ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

Author keywords

AD biomarkers; Alzheimer's disease (AD); CSF; MCI; MRI; Multimodal classification; PET

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; COGNITION DISORDERS; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES;

EID: 79952073234     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.01.008     Document Type: Article

References (66)

1. Apostolova L.G., Hwang K.S., Andrawis J.P., Green A.E., Babakchanian S., Morra J.H., Cummings J.L., Toga A.W., Trojanowski J.Q., Shaw L.M., Jack C.R., Petersen R.C., Aisen P.S., Jagust W.J., Koeppe R.A., Mathis C.A., Weiner M.W., Thompson P.M. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol. Aging 2010, 31:1284-1303.
2. Bouwman F.H., Schoonenboom S.N., van der Flier W.M., van Elk E.J., Kok A., Barkhof F., Blankenstein M.A., Scheltens P. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment. Neurobiol. Aging 2007, 28:1070-1074.
3. Bouwman F.H., van der Flier W.M., Schoonenboom N.S., van Elk E.J., Kok A., Rijmen F., Blankenstein M.A., Scheltens P. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007, 69:1006-1011.
4. Chang C.C., Lin C.J. LIBSVM: a library for support vector machines 2001.
5. Chetelat G., Desgranges B., de la Sayette V., Viader F., Eustache F., Baron J.-C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. NeuroReport 2002, 13:1939-1943.
6. Chetelat G., Desgranges B., de la Sayette V., Viader F., Eustache F., Baron J.C. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology 2003, 60:1374-1377.
7. Chetelat G., Eustache F., Viader F., De La Sayette V., Pelerin A., Mezenge F., Hannequin D., Dupuy B., Baron J.C., Desgranges B. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 2005, 11:14-25.
8. Convit A., de Asis J., de Leon M.J., Tarshish C.Y., De Santi S., Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol. Aging 2000, 21:19-26.
9. Cuingnet, R., Gerardin, E., Tessieras, J., Auzias, G., Lehericy, S., Habert, M.O., Chupin, M., Benali, H., Colliot, O., in press. Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage. doi:10.1016/j.neuroimage.2010.06.013.
10. Davatzikos, C., Bhatt, P., Shaw, L.M., Batmanghelich, K.N., Trojanowski, J.Q., in press. Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2010.05.023.
11. De Bie T., Tranchevent L.C., van Oeffelen L.M., Moreau Y. Kernel-based data fusion for gene prioritization. Bioinformatics 2007, 23:i125-132.
12. de Leon M.J., Mosconi L., Li J., De Santi S., Yao Y., Tsui W.H., Pirraglia E., Rich K., Javier E., Brys M., Glodzik L., Switalski R., Saint Louis L.A., Pratico D. Longitudinal CSF isoprostane and MRI atrophy in the progression to AD. J. Neurol. 2007, 254:1666-1675.
13. De Santi S., de Leon M.J., Rusinek H., Convit A., Tarshish C.Y., Roche A., Tsui W.H., Kandil E., Boppana M., Daisley K., Wang G.J., Schlyer D., Fowler J. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol. Aging 2001, 22:529-539.
14. Desikan R.S., Cabral H.J., Hess C.P., Dillon W.P., Glastonbury C.M., Weiner M.W., Schmansky N.J., Greve D.N., Salat D.H., Buckner R.L., Fischl B. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 2009, 132:2048-2057.
15. Diehl J., Grimmer T., Drzezga A., Riemenschneider M., Forstl H., Kurz A. Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiol. Aging 2004, 25:1051-1056.
16. Drzezga A., Lautenschlager N., Siebner H., Riemenschneider M., Willoch F., Minoshima S., Schwaiger M., Kurz A. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:1104-1113.
17. Du A.T., Schuff N., Kramer J.H., Rosen H.J., Gorno-Tempini M.L., Rankin K., Miller B.L., Weiner M.W. Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain 2007, 130:1159-1166.
18. Duda R.O., Hart P.E., Stork D.G. Pattern Classification 2001, John Wiley and Sons, Inc.
19. Fan Y., Batmanghelich N., Clark C.M., Davatzikos C. Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline. Neuroimage 2008, 39:1731-1743. Initiative, t.A.s.D.N.
20. Fan Y., Resnick S.M., Wu X., Davatzikos C. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. Neuroimage 2008, 41:277-285.
21. Fan Y., Shen D., Gur R.C., Gur R.E., Davatzikos C. COMPARE: Classification Of Morphological Patterns using Adaptive Regional Elements. IEEE Trans. Med. Imaging 2007, 26:93-105.
22. Fellgiebel A., Scheurich A., Bartenstein P., Muller M.J. FDG-PET and CSF phospho-tau for prediction of cognitive decline in mild cognitive impairment. Psychiatry Res. 2007, 155:167-171.
23. Fjell A.M., Walhovd K.B., Fennema-Notestine C., McEvoy L.K., Hagler D.J., Holland D., Brewer J.B., Dale A.M. CSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease. J. Neurosci. 2010, 30:2088-2101.
24. Foster N.L., Heidebrink J.L., Clark C.M., Jagust W.J., Arnold S.E., Barbas N.R., DeCarli C.S., Turner R.S., Koeppe R.A., Higdon R., Minoshima S. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 2007, 130:2616-2635.
25. Fox N., Schott J. Imaging cerebral atrophy: normal ageing to Alzheimer's disease. Lancet 2004, 363:392-394.
26. Gerardin E., Chetelat G., Chupin M., Cuingnet R., Desgranges B., Kim H.S., Niethammer M., Dubois B., Lehericy S., Garnero L., Eustache F., Colliot O. Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage 2009, 47:1476-1486.
27. Geroldi C., Rossi R., Calvagna C., Testa C., Bresciani L., Binetti G., Zanetti O., Frisoni G.B. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2006, 77:1219-1222.
28. Higdon R., Foster N.L., Koeppe R.A., DeCarli C.S., Jagust W.J., Clark C.M., Barbas N.R., Arnold S.E., Turner R.S., Heidebrink J.L., Minoshima S. A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging. Stat. Med. 2004, 23:315-326.
29. Hinrichs C., Singh V., Mukherjee L., Xu G., Chung M.K., Johnson S.C. Spatially augmented LPboosting for AD classification with evaluations on the ADNI dataset. Neuroimage 2009, 48:138-149.
30. Hinrichs C., Singh V., Xu G., Johnson S. MKL for robust multi-modality AD classification. Med. Image Comput. Comput. Assist. Interv. 2009, 12:786-794.
31. Hinrichs, C., Singh, V., Xu, G., Johnson, S., in press. Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage. doi:10.1016/j.neuroimage.2010.10.081.
32. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
33. Jack C.R., Petersen R.C., Y.C.X., O'Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52:1397-1403.
34. Ji Y., Permanne B., Sigurdsson E.M., Holtzman D.M., Wisniewski T. Amyloid b40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice. J. Alzheimers Dis. 2001, 3:23-30.
35. Kabani N., MacDonald D., Holmes C.J., Evans A. A 3D atlas of the human brain. Neuroimage 1998, 7:S717.
36. Kloppel S., Stonnington C.M., Chu C., Draganski B., Scahill R.I., Rohrer J.D., Fox N.C., Jack C.R., Ashburner J., Frackowiak R.S. Automatic classification of MR scans in Alzheimer's disease. Brain 2008, 131:681-689.
37. Lanckriet G.R., Deng M., Cristianini N., Jordan M.I., Noble W.S. Kernel-based data fusion and its application to protein function prediction in yeast. Pac. Symp. Biocomput. 2004, 300-311.
38. Landau S.M., Harvey D., Madison C.M., Reiman E.M., Foster N.L., Aisen P.S., Petersen R.C., Shaw L.M., Trojanowski J.Q., Jack C.R., Weiner M.W., Jagust W.J. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010, 75:230-238.
39. Lao Z., Shen D., Xue Z., Karacali B., Resnick S.M., Davatzikos C. Morphological classification of brains via high-dimensional shape transformations and machine learning methods. Neuroimage 2004, 21:46-57.
40. Lerch J.P., Pruessner J., Zijdenbos A.P., Collins D.L., Teipel S.J., Hampel H., Evans A.C. Automated cortical thickness measurements from MRI can accurately separate Alzheimer's patients from normal elderly controls. Neurobiol. Aging 2008, 29:23-30.
41. Magnin B., Mesrob L., Kinkingnehun S., Pelegrini-Issac M., Colliot O., Sarazin M., Dubois B., Lehericy S., Benali H. Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI. Neuroradiology 2009, 51:73-83.
42. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S.K., van der Flier W.M., Blankenstein M.A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosen E., Aarsland D., Visser P.J., Schroder J., Marcusson J., de Leon M., Hampel H., Scheltens P., Pirttila T., Wallin A., Jonhagen M.E., Minthon L., Winblad B., Blennow K. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009, 302:385-393.
43. McEvoy L.K., Fennema-Notestine C., Roddey J.C., Hagler D.J., Holland D., Karow D.S., Pung C.J., Brewer J.B., Dale A.M. Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment. Radiology 2009, 251:195-205.
44. Misra C., Fan Y., Davatzikos C. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI. Neuroimage 2009, 44:1415-1422.
45. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 2001, 58:397-405.
46. Nestor P.J., Scheltens P., Hodges J.R. Advances in the early detection of Alzheimer's disease. Nat. Med. 2004, 10(Suppl):S34-41.
47. Oliveira P.J., Nitrini R., Busatto G., Buchpiguel C., Sato J., Amaro E.J. Use of SVM methods with surface-based cortical and volumetric subcortical measurements to detect Alzheimer's disease. J. Alzheimers Dis. 2010, 18:1263-1272.
48. Querbes O., Aubry F., Pariente J., Lotterie J.A., Demonet J.F., Duret V., Puel M., Berry I., Fort J.C., Celsis P. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve. Brain 2009, 132:2036-2047.
49. Ron B., Elizabeth J., Kathryn Z.-G., Arrighi H.M. Forecasting the global burden of Alzheimer's disease. Alzheimers Demen J. Alzheimers Assoc. 2007, 3:186-191.
50. Scholkopf B., Smola A. Learning with Kernels 2002, The MIT Press.
51. Shattuck D.W., Sandor-Leahy S.R., Schaper K.A., Rottenberg D.A., Leahy R.M. Magnetic resonance image tissue classification using a partial volume model. Neuroimage 2001, 13:856-876.
52. Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V.M., Trojanowski J.Q. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann. Neurol. 2009, 65:403-413.
53. Shen D., Davatzikos C. HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans. Med. Imaging 2002, 21:1421-1439.
54. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
55. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
56. Tan A.C., Gilbert D. Ensemble machine learning on gene expression data for cancer classification. Appl. Bioinform. 2003, 2:S75-83.
57. Vemuri P., Wiste H.J., Weigand S.D., Shaw L.M., Trojanowski J.Q., Weiner M.W., Knopman D.S., Petersen R.C., Jack C.R. MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change. Neurology 2009, 73:294-301.
58. Visser P.J., Verhey F.R.J., Hofman P.A., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2002, 72:491-497.
59. Walhovd K.B., Fjell A.M., Brewer J., McEvoy L.K., Fennema-Notestine C., Hagler D.J., Jennings R.G., Karow D., Dale A.M. Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am. J. Neuroradiol. 2010, 31:347-354.
60. Walhovd K.B., Fjell A.M., Dale A.M., McEvoy L.K., Brewer J., Karow D.S., Salmon D.P., Fennema-Notestine C. Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol. Aging 2010, 31:1107-1121.
61. Wang Z., Chen S., Sun T. MultiK-MHKS: a novel multiple kernel learning algorithm. IEEE Trans. Pattern Anal. Mach. Intell. 2008, 30:348-353.
62. West M., Kawas C., Stewart W., Rudow G., Troncoso J. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging 2004, 25:1205-1212.
63. Westman E., Simmons A., Zhang Y., Muehlboeck J.S., Tunnard C., Liu Y., Collins L., Evans A., Mecocci P., Vellas B., Tsolaki M., Kloszewska I., Soininen H., Lovestone S., Spenger C., Wahlund L.O. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage 2011, 54:1178-1187.
64. Ye J., Chen K., Wu T., Li J., Zhao Z., Patel R., Bae M., Janardan R., Liu H., Alexander G., Reiman E.M. Heterogeneous data fusion for Alzheimer's disease study. KDD'08 2008.
65. Yu S., Falck T., Daemen A., Tranchevent L.C., Suykens J.A., De Moor B., Moreau Y. L2-norm multiple kernel learning and its application to biomedical data fusion. BMC Bioinform. 2010, 11:309.
66. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation maximization algorithm. IEEE Trans. Med. Imaging 2001, 20:45-57.